The Value of <sup>68</sup>Ga-PSMA PET/CT Following Equivocal <sup>18</sup>F-NaF PET/CT in Prostate Cancer Patients
Background: Inconclusive bone scans are a challenge but there is no consensus about follow-up imaging. We evaluated the use of <sup>68</sup>gallium-labelled prostate-specific membrane antigen (<sup>68</sup>Ga-PSMA) PET/CT if <sup>18</sup>F-sodium fluoride (<sup...
| Hlavní autoři: | , , |
|---|---|
| Médium: | Článek |
| Jazyk: | English |
| Vydáno: |
MDPI AG
2020-05-01
|
| Edice: | Diagnostics |
| Témata: | |
| On-line přístup: | https://www.mdpi.com/2075-4418/10/6/352 |